BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  ENHERTU® Plus Pertuzumab Granted Priority Review in the U.S. as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer

  September 24, 2025

   · 

  19 min read
• Press Releases

  Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025

  September 24, 2025

   · 

  18 min read
• Press Releases

  New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies

  September 24, 2025

   · 

  15 min read
• Press Releases

  Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025

  September 24, 2025

   · 

  10 min read
• Press Releases

  Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

  September 24, 2025

   · 

  6 min read
• Press Releases

  Burning Rock’s OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

  September 24, 2025

   · 

  4 min read
• Press Releases

  Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health

  September 24, 2025

   · 

  3 min read
• Press Releases

  Press release: Availability of the Q3 2025 Aide mémoire

  September 24, 2025

   · 

  4 min read
• Press Releases

  Palvella Therapeutics Announces Expansion of QTORIN™ Rapamycin’s Development into Clinically Significant Angiokeratomas, a Rare, Chronically Debilitating Lymphatic Disease with No FDA-approved Therapies

  September 24, 2025

   · 

  7 min read
• Press Releases

  Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101

  September 24, 2025

   · 

  7 min read